BrainStorm Cell Therapeutics Inc. (BCLI) income statement
BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.77−0.01 (-1.17%)
Close on Oct 19, 2026Market cap $8.50MP/E –Yield –
BrainStorm Cell Therapeutics Inc. financial ratios
See a number that looks wrong?